Cite
HARVARD Citation
Yaman, S. et al. (2019). Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?. Future oncology. pp. 925-927. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yaman, S. et al. (2019). Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?. Future oncology. pp. 925-927. [Online].